Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for MMS and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MMS and 80,000+ other tickers.
See exactly how MMS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MMS and 80,000+ other tickers.
Maximus, Inc. specializes in delivering business process services (BPS) tailored for governmental health and human welfare initiatives. Its operations are structured into three main divisions: U.S. Services, U.S. Federal Services, and International Services. The U.S. Services division delivers a wide array of BPS solutions to state and local government programs across the United States. These offerings encompass program administration, handling appeals and evaluations, and providing specialized consulting. Key programs supported include the Affordable Care Act, Medicaid, the Children's Health…
[url="]LitePoint[/url], a leading provider of communication test solutions, today announced the successful validation of physical layer (PHY) performance for ST
Bank of America Corp DE lessened its position in Maximus, Inc. (NYSE: MMS) by 19.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 563,486 shares of the health services provider's stock after selling 137,118 shares during the quarter. Bank of America Corp
Maximus faces an earnings reset as paused VA incentives cut profit and cash-flow guidance, testing whether service and tech gains can rebuild momentum.
Maximus trades at a deep earnings discount, but federal procurement delays and weak award conversion cloud the timing of a recovery.
Maximus NYSE: MMS reported fiscal 2026 third-quarter revenue of $1.28 billion, with adjusted EBITDA margin of 15.0% and adjusted diluted earnings per share of $2.22. Revenue was in line with the company's expectations, while adjusted EBITDA margin improved from 14.7% a year earlier and adjusted EPS rose from $2.16.